Table 2.
Microbial changes as a result of several treatments in viral B and C hepatitis
Drug |
Type of study |
Changes in gut microbiota |
Ref. |
Entecavir | Experimental (mice) | ↑ Lachnospiraceae, Akkermansia, Alistipes, Escherichia, Shigella, Oscillibacter, Bilophila | Li et al[127] |
Clinical | ↑ Clostridium sensu stricto 1, Erysipelotrichaceae UCG-007, Intestinibacter; ↓ Streptococcus, Atopobium, and Murdochiella | Lu et al[128] | |
Direct antiviral agents in patients with HCV infection | Clinical | ↑ Phylum Firmicutes, genera Lachnospira | Pérez-Matute et al[129] |
Direct antiviral agents in patients with HCV-related liver cirrhosis | Clinical | ↓ Enterobacteriaceae, Staphylococcus and Veillonellaceae | Ponziani et al[130] |
HCV: Hepatitis C virus.